trial · primary record
Venetoclax
Acute Myeloid Leukemia
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 650 |
| Primary completion | 2032-02 |
| Primary endpoint | Event Free Survival (EFS) |
| Registry ID | NCT04628026 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:24.512Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04628026
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- VENETOCLAX · approval
- Venetoclax · compound